Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureAdriana Verónica Balderas Loaeza, Bertha Josefina Espinoza Gutiérrez, Irene Cruz Mendoza, Abel Edmundo Villa Mancera, José Manuel Robles Robles, Héctor Quiroz Romero, Alfredo Sahagún Ruiz, Samuel Ortega Vargas
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Epidemiology of fascioliasis in human endemic areas
10.1079/joh2005296 · 2005
Chapter 2 Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control
10.1016/s0065-308x(09)69002-3 · 2009
An update on the pathogenesis of fascioliasis: what do we know?
2024
Fasciola hepatica vaccine: we may not be there yet but we’re on the right road
10.1016/j.vetpar.2015.01.004 · 2015
Fasciolosis—an increasing challenge in the sheep industry
10.3390/ani12121491 · 2022
Human and animal fascioliasis: origins and worldwide evolving scenario
10.1128/cmr.00088-19 · 2022
Triclabendazole and other fasciolicides: resistance of Fasciola hepatica in ruminants
10.3390/ani16071044 · 2026
Dynamic immune modulation in fasciolosis: from protective to permissive responses
10.1016/j.actatropica.2026.108087 · 2026
Omics tools enabling vaccine discovery against fasciolosis
10.1016/j.pt.2022.09.009 · 2022
Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1016/j.vaccine.2019.04.067 · 2019
Evaluation of Quillaja brasiliensis saponin-based nanoparticles combined with leucine aminopeptidases for immunoprotection of sheep against Fasciola hepatica
10.3390/vaccines13101008 · 2025
Fasciola hepatica antioxidant and protease-inhibitor cocktail recombinant vaccines administered five times elicit potent and sustained immune responses in sheep but do not confer protection
10.1016/j.vetpar.2023.110049 · 2023
Fasciola hepatica: vaccination of rabbits with native and recombinant antigens related to fatty acid binding proteins
10.1016/s0304-4017(96)01131-4 · 1997
Fasciola hepatica vaccine based on Kunitz-type molecule reduces adult worm fecundity in experimentally infected sheep
10.1016/j.vetpar.2025.110654 · 2026
Quantitation of cytokine mRNA by real-time RT-PCR during a vaccination trial in a rabbit model of fascioliasis
10.1016/j.vetpar.2009.12.018 · 2009
Differential expression and localization of saposin-like protein 2 of Fasciola hepatica
10.1016/j.actatropica.2013.08.012 · 2013
Molecular cloning of a member of the Fasciola hepatica saposin-like protein family
10.1645/ge-3113 · 2003
Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis
10.1016/j.diagmicrobio.2011.03.016 · 2011
Expression, purification and in vitro refolding of the recombinant truncated Saposin-like protein 2 antigen for development of diagnosis of human fascioliasis
10.1016/j.actatropica.2017.03.002 · 2017
Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica
10.1016/j.exppara.2015.11.002 · 2016
Fasciola hepatica: humoral and cytokine responses to a member of the saposin-like protein family following delivery as a DNA vaccine in mice
10.1016/j.exppara.2005.03.029 · 2005
Fasciola hepatica: identification of CD4+ T-helper epitopes from the 11.5kDa Saposin-like protein SAP-2 using synthetic peptides
10.1016/j.exppara.2007.03.012 · 2007
A modified variant of Fasciola hepatica FhSAP-2 (mFhSAP-2) as a recombinant vaccine candidate induces high-avidity IgG2c antibodies and enhances T cell activation in C57BL/6 mice
2025
Evaluation of antibody response of sheep to foot-and-mouth disease vaccine prepared by using different MontanideTM oil adjuvants
10.47665/tb.38.1.027 · 2021
The immunogenicity and tissue reactivity of Mycobacterium avium subsp paratuberculosis inactivated whole cell vaccine is dependent on the adjuvant used
10.1016/j.heliyon.2019.e01911 · 2019
Immune induction by adjuvanted Leishmania donovani vaccines against the visceral leishmaniasis in BALB/c mice
10.1016/j.imbio.2021.152057 · 2021
Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle
10.1016/j.vaccine.2013.05.078 · 2013
Immunoenhancing effects of Montanide ISA oil-based adjuvants on recombinant coccidia antigen vaccination against Eimeria acervulina infection
10.1016/j.vetpar.2010.04.042 · 2010
Exposure to Fasciola hepatica miracidia increases the sensitivity of Lymnaea (Fossaria) humilis to high and low pH
10.1645/ge-3542rn.1 · 2006
Vaccines for Fasciola: new thinking for an old problem
2021
The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep
10.1016/j.vaccine.2011.09.020 · 2011
Comparative analysis of the viability of Fasciola hepatica eggs collected from fecal and gallbladder samples in experimentally infected sheep
10.1016/j.vetpar.2025.110631 · 2025
Vaccination with cathepsin L phage-exposed mimotopes, single or in combination, reduce size, fluke burden, egg production and viability in sheep experimentally infected with Fasciola hepatica
10.1016/j.parint.2021.102355 · 2021
Liver fluke vaccines in ruminants: strategies, progress and future opportunities
10.1016/j.ijpara.2014.07.011 · 2014
The failure of a DNA prime/protein boost regime and CTLA-4 mediated targeting to improve the potency of a DNA vaccine encoding Fasciola hepatica phosphoglycerate kinase in sheep
10.1016/j.vetimm.2019.109941 · 2019
Vaccination of sheep with Quil-A® adjuvant expands the antibody repertoire to the Fasciola MF6p/FhHDM-1 antigen and administered together impair the growth and antigen release of flukes
10.1016/j.vaccine.2018.02.115 · 2018
Evaluation of a novel vaccine candidate derived from newly excysted juveniles of Fasciola hepatica in sheep
10.1038/s41598-025-00109-z · 2025
Vaccination with cathepsin L mimotopes of Fasciola hepatica in goats reduces worm burden, morphometric measurements, and reproductive structures
10.1016/j.micpath.2021.104859 · 2021
Pathological, immunological and parasitological study of sheep vaccinated with the recombinant protein 14-3-3z and experimentally infected with Fasciola hepatica
10.1016/j.vetimm.2018.07.006 · 2018
Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica
10.1016/s0264-410x(97)00289-2 · 1998
Helminth vaccines in ruminants: from development to application
10.1016/j.cvfa.2019.10.001 · doi-reference
Safety and immunogenicity of an FhSAMS vaccine against Fasciola hepatica in dairy cattle
10.1111/pim.13074 · doi-reference
Efficacy of a multivalent vaccine against Fasciola hepatica infection in sheep
10.1186/s13567-021-00895-0 · doi-reference
Phage display-based vaccine with cathepsin L and excretory-secretory products mimotopes of Fasciola hepatica induces protective cellular and humoral immune responses in sheep
10.1016/j.vetpar.2020.109340 · doi-reference